Idera Pharmaceuticals Company Profile (NASDAQ:IDRA)

About Idera Pharmaceuticals

Idera Pharmaceuticals logoIdera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapeutics for oncology and rare diseases. The Company utilizes two drug discovery technology platforms to design and develop drug candidates, which include Toll-like receptor (TLR) targeting technology and third-generation antisense (3GA) technology. Using TLR technology, the Company designs synthetic oligonucleotide-based drug candidates to act by modulating the activity of specific TLRs. Using its 3GA technology, the Company is developing drug candidates to turn off the messenger ribo nucleic acid (mRNA) associated with disease causing genes. The Company's drug candidates include IMO-8400; IMO-2125/IMO-2055, and IMO-9200. The Company's TLR antagonist lead drug candidates are IMO-8400 and IMO-9200, which are both antagonists of TLR7, TLR8 and TLR9. Its TLR agonist lead drug candidates are IMO-2055 and IMO-2125, which are both agonists of TLR9.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: IDRA
  • CUSIP:
Key Metrics:
  • Previous Close: $1.95
  • 50 Day Moving Average: $1.76
  • 200 Day Moving Average: $1.73
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.06
  • P/E Growth: 0.00
  • Market Cap: $236.69M
  • Outstanding Shares: 121,378,000
  • Beta: 2.76
Additional Links:
Companies Related to Idera Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Idera Pharmaceuticals (NASDAQ:IDRA) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.50 (233.33% upside)

Analysts' Ratings History for Idera Pharmaceuticals (NASDAQ:IDRA)
Show:
DateFirmActionRatingPrice TargetDetails
8/2/2016WedbushReiterated RatingOutperform$6.00View Rating Details
5/10/2016Cowen and CompanyReiterated RatingBuyView Rating Details
3/12/2016Piper Jaffray Cos.Reiterated RatingBuyView Rating Details
6/15/2015JPMorgan Chase & Co.Initiated CoverageOverweight$6.00View Rating Details
(Data available from 8/24/2014 forward)

Earnings

Earnings History for Idera Pharmaceuticals (NASDAQ:IDRA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/4/2016        
8/2/2016Q216($0.11)($0.11)ViewN/AView Earnings Details
5/9/2016Q1($0.11)($0.11)ViewListenView Earnings Details
3/10/2016Q4($0.11)($0.10)$20.00 millionViewN/AView Earnings Details
11/6/2015Q315($0.11)($0.10)ViewN/AView Earnings Details
8/6/2015Q215($0.11)($0.11)ViewN/AView Earnings Details
5/11/2015Q1($0.11)($0.12)$0.03 millionViewN/AView Earnings Details
3/12/2015Q414($0.11)($0.14)$0.03 millionViewN/AView Earnings Details
11/7/2014Q314($0.11)($0.11)ViewListenView Earnings Details
8/12/2014Q214($0.09)($0.10)ViewListenView Earnings Details
5/13/2014Q114($0.08)($0.12)ViewListenView Earnings Details
3/13/2014Q4($0.08)($0.10)ViewListenView Earnings Details
11/14/2013Q3($0.11)($0.11)$0.03 million$0.01 millionViewListenView Earnings Details
8/15/2013Q213($0.12)($0.15)ViewN/AView Earnings Details
5/15/2013Q113($0.19)($0.15)ViewN/AView Earnings Details
3/11/2013Q4 2012($0.24)ViewN/AView Earnings Details
11/12/2012Q312($0.17)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Idera Pharmaceuticals (NASDAQ:IDRA)
Current Year EPS Consensus Estimate: $-0.45 EPS
Next Year EPS Consensus Estimate: $-0.48 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.11)($0.10)($0.11)
Q2 20161($0.11)($0.11)($0.11)
Q3 20162($0.11)($0.09)($0.10)
Q4 20161($0.10)($0.10)($0.10)
Q1 20171($0.10)($0.10)($0.10)
Q2 20171($0.11)($0.11)($0.11)
Q3 20171($0.10)($0.10)($0.10)
Q4 20171($0.10)($0.10)($0.10)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Idera Pharmaceuticals (NASDAQ:IDRA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Idera Pharmaceuticals (NASDAQ:IDRA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/13/2016James A GeraghtyDirectorBuy10,000$1.34$13,400.00View SEC Filing  
5/12/2016Mark J CaseyVPBuy34,450$1.44$49,608.00View SEC Filing  
3/15/2016Vincent MilanoCEOBuy40,000$1.97$78,800.00View SEC Filing  
2/13/2015Julian BakerDirectorBuy5,333,333$3.75$19,999,998.75View SEC Filing  
12/16/2014Youssef El ZeinDirectorSell100,000$3.68$368,000.00View SEC Filing  
12/12/2014Vincent MilanoCEOBuy200,000$4.00$800,000.00View SEC Filing  
5/27/2014James A GeraghtyDirectorBuy10,000$2.65$26,500.00View SEC Filing  
12/6/2013James A GeraghtyDirectorBuy40,000$2.72$108,800.00View SEC Filing  
9/16/2013James A GeraghtyDirectorBuy60,000$1.90$114,000.00View SEC Filing  
8/19/2013James A GeraghtyDirectorBuy300,000$1.75$525,000.00View SEC Filing  
5/7/2013C Keith HartleyDirectorBuy90,000$0.49$44,100.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Idera Pharmaceuticals (NASDAQ:IDRA)
DateHeadline
News IconSmall Cap Insight on Shares of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - Duncan Research (NASDAQ:IDRA)
www.duncanindependent.com - August 20 at 5:25 PM
News IconCrowd Perspectives & Analyst Views on Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)? - Post News (NASDAQ:IDRA)
www.kentuckypostnews.com - August 20 at 9:46 AM
News IconEarnings in Perspective for Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - Post News (NASDAQ:IDRA)
www.kentuckypostnews.com - August 19 at 5:32 PM
News IconPenny Stock Alert - Update & Review on This Stock: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - Duncan Research (NASDAQ:IDRA)
www.duncanindependent.com - August 19 at 5:32 PM
investornewswire.com logoWill Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Hit $6 Price Target? - Investor Newswire (NASDAQ:IDRA)
www.investornewswire.com - August 19 at 5:32 PM
kcregister.com logoMorning Alert: Idera Pharmaceuticals (NASDAQ:IDRA), Allot ... - KC Register (NASDAQ:IDRA)
www.kcregister.com - August 18 at 5:35 PM
News IconTaking A Closer Look at Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - Duncan Research (NASDAQ:IDRA)
www.duncanindependent.com - August 18 at 8:35 AM
News IconSmall Cap Update on: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - Duncan Research (NASDAQ:IDRA)
www.duncanindependent.com - August 16 at 5:46 PM
News IconA Closer Look at Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - Duncan Research (NASDAQ:IDRA)
www.duncanindependent.com - August 16 at 5:46 PM
finance.yahoo.com logoIdera to Present at the 2016 Wedbush PacGrow Healthcare Conference (NASDAQ:IDRA)
finance.yahoo.com - August 12 at 5:38 PM
capitalcube.com logoETF’s with exposure to Idera Pharmaceuticals, Inc. : August 12, 2016 (NASDAQ:IDRA)
www.capitalcube.com - August 12 at 5:38 PM
capitalcube.com logoIdera Pharmaceuticals, Inc. :IDRA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 (NASDAQ:IDRA)
www.capitalcube.com - August 11 at 5:49 PM
streetupdates.com logoAnalyst's Notable Buzzers: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) , Emergent Biosolutions, Inc. (NYSE:EBS) - Street Updates (NASDAQ:IDRA)
www.streetupdates.com - August 10 at 8:25 AM
streetupdates.com logoNotable Stocks within Analysts Radar: STERIS Corporation (NYSE:STE) , Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - Street Updates (NASDAQ:IDRA)
www.streetupdates.com - August 10 at 8:25 AM
finance.yahoo.com logoIDERA PHARMACEUTICALS, INC. Financials (NASDAQ:IDRA)
finance.yahoo.com - August 6 at 5:47 PM
equities.com logoIdera Pharmaceuticals Inc. (IDRA) is Trading Higher on Unusual Volume for August 04 - Equities.com (NASDAQ:IDRA)
www.equities.com - August 6 at 8:26 AM
streetupdates.com logoRecent Price Moves of Shares: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) , ZELTIQ Aesthetics, Inc. (NASDAQ:ZLTQ) - Street Updates (NASDAQ:IDRA)
www.streetupdates.com - August 5 at 8:31 AM
smarteranalyst.com logoWedbush Provides Commentary on Idera Pharmaceuticals Inc (IDRA) Following 2Q Update - Smarter Analyst (NASDAQ:IDRA)
www.smarteranalyst.com - August 5 at 8:31 AM
smarteranalyst.com logoWedbush Provides Commentary on Idera Pharmaceuticals Inc ... - Smarter Analyst (NASDAQ:IDRA)
www.smarteranalyst.com - August 4 at 8:35 AM
twst.com logoIdera Pharmaceuticals Inc.: Idera Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:IDRA)
www.twst.com - August 2 at 10:23 AM
sg.finance.yahoo.com logoIdera reports 2Q loss (NASDAQ:IDRA)
sg.finance.yahoo.com - August 2 at 10:23 AM
stocksdaily.net logoIdera Pharmaceuticals, Inc. (NASDAQ:IDRA) Cash Balance At $60.16 Millions - Stocks Daily (NASDAQ:IDRA)
www.stocksdaily.net - July 28 at 8:33 AM
News IconHC Stocks Outlines: Idera Pharmaceuticals Inc (NASDAQ:IDRA), StemCells Inc (NASDAQ:STEM) - share market updates (press release) (NASDAQ:IDRA)
sharemarketupdates.com - July 26 at 8:34 AM
investornewswire.com logoIs $6 Price Target Attainable For Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)? - Investor Newswire (NASDAQ:IDRA)
www.investornewswire.com - July 23 at 5:19 PM
stocksdaily.net logoCash And Short-Term Investments For Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Was $60.16 - Stocks Daily (NASDAQ:IDRA)
www.stocksdaily.net - July 22 at 8:31 AM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - TGP (NASDAQ:IDRA)
telanaganapress.com - July 21 at 5:45 PM
News IconIdera Pharmaceuticals Incorporated (NASDAQ:IDRA) Shorted Shares Increased 7.74% After Market Selling - Consumer Eagle (NASDAQ:IDRA)
www.consumereagle.com - July 21 at 5:45 PM
fiscalstandard.com logoBroker Outlook For Idera Pharmaceuticals, Inc. (IDRA) - Fiscal Standard (NASDAQ:IDRA)
www.fiscalstandard.com - July 21 at 5:45 PM
News IconIdera Pharmaceuticals, Inc. (NASDAQ:IDRA): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:IDRA)
www.engelwooddaily.com - July 20 at 8:33 AM
News IconTrading Performance and Target Watch for Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - Press Telegraph (NASDAQ:IDRA)
presstelegraph.com - July 18 at 10:48 AM
News IconShares Moving Down on the Week: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - Engelwood Daily (NASDAQ:IDRA)
www.engelwooddaily.com - July 17 at 5:07 PM
News IconShares Experiencing a Downtrend: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - TGP (NASDAQ:IDRA)
telanaganapress.com - July 17 at 5:07 PM
investornewswire.com logoStrong Sell Calls For Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) At 0 - Investor Newswire (NASDAQ:IDRA)
www.investornewswire.com - July 17 at 5:07 PM
News IconIdera Pharmaceuticals, Inc. (NASDAQ:IDRA) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:IDRA)
www.engelwooddaily.com - July 13 at 8:28 AM
News IconIdera Pharmaceuticals Inc (NASDAQ:IDRA) Institutional Investors Sentiment - Consumer Eagle (NASDAQ:IDRA)
www.consumereagle.com - July 11 at 5:40 PM
fiscalstandard.com logoNext Weeks Broker Price Targets For Idera Pharmaceuticals, Inc. (IDRA) - Fiscal Standard (NASDAQ:IDRA)
www.fiscalstandard.com - July 10 at 5:11 PM
investornewswire.com logoIs $6 Within Reach For Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)? - Investor Newswire (NASDAQ:IDRA)
www.investornewswire.com - July 9 at 8:58 AM
News IconIdera Pharmaceuticals Incorporated (NASDAQ:IDRA) Shorted Shares Increased By 2.89% - Press Telegraph (NASDAQ:IDRA)
presstelegraph.com - July 7 at 5:39 PM
News IconInsiders Increasing Positions in: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - Press Telegraph (NASDAQ:IDRA)
presstelegraph.com - July 7 at 5:39 PM
stocksdaily.net logoIdera Pharmaceuticals, Inc. (NASDAQ:IDRA) Cash And Short-Term Investments In Stands At $60.16 - Stocks Daily (NASDAQ:IDRA)
www.stocksdaily.net - July 7 at 5:39 PM
News IconHC Stocks Reports: Idera Pharmaceuticals Inc (NASDAQ:IDRA), Sequenom, Inc. (NASDAQ:SQNM) - share market updates (press release) (NASDAQ:IDRA)
sharemarketupdates.com - July 5 at 10:11 AM
investornewswire.com logoIdera Pharmaceuticals, Inc. (NASDAQ:IDRA) Expected to Reach Highs Of $6 - Investor Newswire (NASDAQ:IDRA)
www.investornewswire.com - July 2 at 8:29 AM
news.cmlviz.com logoIdera Pharmaceuticals, Inc. Stock Momentum at Critical Inflection Point - CML News (NASDAQ:IDRA)
news.cmlviz.com - July 2 at 8:29 AM
News IconIdera Pharmaceuticals Incorporated (NASDAQ:IDRA) Shorted Shares Increased 2.89% After Market Selling - Engelwood Daily (NASDAQ:IDRA)
www.engelwooddaily.com - July 1 at 8:21 AM
News IconWatching Stock Volatility for: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - Engelwood Daily (NASDAQ:IDRA)
www.engelwooddaily.com - June 30 at 8:27 AM
ftsenews.co.uk logoIdera Pharmaceuticals, Inc. (IDRA) Updated Price Targets - FTSE News (NASDAQ:IDRA)
www.ftsenews.co.uk - June 30 at 8:27 AM
News IconIdera Pharmaceuticals, Inc. (NASDAQ:IDRA) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:IDRA)
www.engelwooddaily.com - June 28 at 5:31 PM
News IconIdera Pharmaceuticals Incorporated (NASDAQ:IDRA) Sellers Increased By 2.89% Their Shorts - Press Telegraph (NASDAQ:IDRA)
presstelegraph.com - June 27 at 5:34 PM
investornewswire.com logoStrong Sell Calls Recommendations For Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) At 0 - Investor Newswire (NASDAQ:IDRA)
www.investornewswire.com - June 25 at 9:25 AM
fiscalstandard.com logoBrokers Issue Average Price Target Of 6.33 On Idera Pharmaceuticals, Inc. (IDRA) - Fiscal Standard (NASDAQ:IDRA)
www.fiscalstandard.com - June 23 at 8:29 AM

Social

Idera Pharmaceuticals (NASDAQ:IDRA) Chart for Wednesday, August, 24, 2016


Last Updated on 8/24/2016 by MarketBeat.com Staff